Modafinilo [Spanish]

Modafinilo [Spanish] Brand names, Modafinilo [Spanish] Analogs

Modafinilo [Spanish] Brand Names Mixture

No information avaliable

Modafinilo [Spanish] Chemical_Formula

C₁₅H₁₅NO₂S

Modafinilo [Spanish] RX_link

http://www.rxlist.com/cgi/generic2/modafinil.htm

Modafinilo [Spanish] fda sheet

Modafinilo_[Spanish] FDA

Modafinilo [Spanish] msds (material safety sheet)

Modafinilo_[Spanish] MSDS

Modafinilo [Spanish] Synthesis Reference

L. Lafon, U.S. pat. 4,927,855, (1990)

Modafinilo [Spanish] Molecular Weight

273.351 g/mol

Modafinilo [Spanish] Melting Point

164-166 ^oC

Modafinilo [Spanish] H₂O Solubility

Slightly soluble

Modafinilo [Spanish] State

Solid

Modafinilo [Spanish] LogP

1.736

Modafinilo [Spanish] Dosage Forms

Tablet

Modafinilo [Spanish] Indication

To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.

Modafinilo [Spanish] Pharmacology

Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. Modafinil is not indicated for complaints of lack of energy or fatigue; but it appears to be very helpful for some patients. Also, it has been used in the treatment of hypersomnia, a disorder in which patients lack the capacity for meaningful sleep and may require ten or more hours per day. Recent studies have have found that modafinil may help recovering cocaine addicts fight their addiction.

Modafinilo [Spanish] Absorption

Rapid following oral administration.

Modafinilo [Spanish] side effects and Toxicity

No information avaliable

Modafinilo [Spanish] Patient Information

Modafinilo [Spanish] Organisms Affected

Humans and other mammals